RWDD2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.863200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.005200E-01
Normal-vs-Stage2
2.607000E-01
Normal-vs-Stage3
6.419000E-01
Normal-vs-Stage4
1.580580E-01
Stage1-vs-Stage2
2.507400E-01
Stage1-vs-Stage3
6.942600E-01
Stage1-vs-Stage4
8.394200E-02
Stage2-vs-Stage3
6.433400E-01
Stage2-vs-Stage4
3.920800E-01
Stage3-vs-Stage4
4.250400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.912800E-01
Normal-vs-AfricanAmerican
2.985800E-01
Normal-vs-Asian
2.422400E-01
Caucasian-vs-AfricanAmerican
9.796000E-01
Caucasian-vs-Asian
6.824200E-01
AfricanAmerican-vs-Asian
8.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.428200E-01
Normal-vs-Female
3.596600E-01
Male-vs-Female
1.450360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.011380E-01
Normal-vs-Age(41-60Yrs)
3.725800E-01
Normal-vs-Age(61-80Yrs)
2.257800E-01
Normal-vs-Age(81-100Yrs)
8.334200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.131600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.042000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.431600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.621600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.605800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.652400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.529200E-01
Normal-vs-Daily Drinker
9.141600E-02
Normal-vs-Weekly Drinker
1.409350E-01
Normal-vs-Occasional Drinker
4.424200E-01
Normal-vs-Social Drinker
8.057400E-01
Non Drinker-vs-Daily Drinker
3.694200E-01
Non Drinker-vs-Weekly Drinker
7.908600E-01
Non Drinker-vs-Occasional Drinker
5.685600E-01
Non Drinker-vs-Social Drinker
9.273600E-02
Daily Drinker-vs-Weekly Drinker
5.808200E-01
Daily Drinker-vs-Occasional Drinker
1.832840E-01
Daily Drinker-vs-Social Drinker
1.531640E-02
Weekly Drinker-vs-Occasional Drinker
4.593400E-01
Weekly Drinker-vs-Social Drinker
7.173500E-02
Occasional Drinker-vs-Social Drinker
3.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.279900E-02
Normal-vs-Grade 2
4.459000E-03
Normal-vs-Grade 3
1.944500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.690200E-01
Grade 1-vs-Grade 3
2.287400E-01
Grade 1-vs-Grade 4
8.279900E-02
Grade 2-vs-Grade 3
7.512600E-01
Grade 2-vs-Grade 4
4.459000E-03
Grade 3-vs-Grade 4
1.944500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.729630E-01
Normal-vs-NonDiabetic
2.918600E-01
Diabetic-vs-NonDiabetic
1.362410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.775200E-01
Normal-vs-NoPancreatitis
2.458600E-01
Pancreatitis-vs-NoPancreatitis
2.699200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.886200E-01
Normal-vs-N1
2.554000E-01
N0-vs-N1
9.478800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.588600E-01
Normal-vs-TP53-NonMutant
4.917000E-01
TP53-Mutant-vs-TP53-NonMutant
3.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
